Complement in Kidney Transplantation

Area of Science:

• Immunology
• Nephrology
• Transplantation Science

Background:

• The complement system, a key part of innate immunity, bridges innate and adaptive immunity.
• Dysregulation of the complement system is implicated in kidney diseases like atypical hemolytic uremic syndrome (aHUS) and C3 glomerulopathy (C3GN).
• Complement activation significantly contributes to post-kidney transplant complications, including ischemia-reperfusion injury (IRI), delayed graft function (DGF), antibody-mediated rejection (ABMR), and thrombotic microangiopathy (TMA).

Purpose of the Study:

• To review the complement cascade's role in kidney diseases and transplantation.
• To identify therapeutic targets within the complement system.
• To discuss novel therapeutics aimed at improving kidney graft survival.

Main Methods:

• Literature review of the complement cascade.
• Analysis of complement's involvement in kidney pathology and transplantation outcomes.
• Survey of current and emerging complement-targeting therapies.

Main Results:

• The complement system is integral to both native kidney diseases and post-transplant complications.
• Targeting the complement cascade offers potential strategies for preventing and managing adverse transplant events.
• Novel therapeutics targeting the complement system are under development to enhance graft survival.

Conclusions:

• A comprehensive understanding of the complement cascade is essential for managing kidney transplant patients.
• Targeting complement pathways presents a promising avenue for improving kidney allograft outcomes.
• Emerging complement inhibitors represent a significant advancement in transplantation medicine.